Whitepapers/App Notes/Posters

Application note: Robust by design – how BD is overcoming the biologics challenge in drug delivery

Posted: 25 August 2020 | | No comments yet

This application note explores how BD is dedicated to deliver best-in-class product performance and services by applying the latest advances in drug delivery technology.

Becton, Dickinson and Company (BD) is developing a 2.25mL dose volume fully integrated autoinjector with BD Neopak XtraFlow – BD’s latest pre-fillable glass-based syringe system featuring an 8mm needle with ultra-thin wall cannula technology. BD has designed autoinjectors that can deliver drugs of differing viscosities in a well-integrated robust system. Pharmaceutical companies can adapt BD Intevia to deliver a range of drug volumes and viscosities without any need for customisation of the system or its components.











    To read this Application Note in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Becton Dickinson

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend